Ninth Circuit Considers Limits to DEA Access to Oregon Prescription Drug Monitoring Program - McDermott Will & Emery

Ninth Circuit Considers Limits to DEA Access to Oregon Prescription Drug Monitoring Program

Overview


Karen Owen Gibbs and Patrick Callaghan were cited for their article on Oregon Prescription Drug Monitoring Program v. US, a Ninth Circuit case with potentially wide-ranging privacy implications involving Drug Enforcement Administration use of administrative subpoenas to access records from the Prescription Drug Monitoring Program.